The common cold or the cold is a viral infectious disease of the upper respiratory tract that primarily affects the respiratory mucosa of the nose, throat, sinuses, and larynx. Signs and symptoms may appear fewer than two days after exposure to the virus. These may include coughing, sore throat, runny nose, sneezing, headache, and fever. People usually recover in seven to ten days, but some symptoms may last up to three weeks. Occasionally, those with other health problems may develop pneumonia.
Severe acute respiratory syndrome (SARS) is a viral respiratory disease of zoonotic origin caused by the severe acute respiratory syndrome coronavirus, the first identified strain of the SARS coronavirus species, severe acute respiratory syndrome–related coronavirus (SARSr-CoV). The first known cases occurred in November 2002, and the syndrome caused the 2002–2004 SARS outbreak. In the 2010s, Chinese scientists traced the virus through the intermediary of Asian palm civets to cave-dwelling horseshoe bats in Xiyang Yi Ethnic Township, Yunnan.
Cold medicines are a group of medications taken individually or in combination as a treatment for the symptoms of the common cold and similar conditions of the upper respiratory tract. The term encompasses a broad array of drugs, including analgesics, antihistamines and decongestants, among many others. It also includes drugs which are marketed as cough suppressants or antitussives, but their effectiveness in reducing cough symptoms is unclear or minimal.
An upper respiratory tract infection (URTI) is an illness caused by an acute infection, which involves the upper respiratory tract, including the nose, sinuses, pharynx, larynx or trachea. This commonly includes nasal obstruction, sore throat, tonsillitis, pharyngitis, laryngitis, sinusitis, otitis media, and the common cold. Most infections are viral in nature, and in other instances, the cause is bacterial. URTIs can also be fungal or helminthic in origin, but these are less common.
A vaporizer or vaporiser, colloquially known as a vape, is a device used to vaporize substances for inhalation. Plant substances can be used, commonly cannabis, tobacco, or other herbs or blends of essential oil. However, they are most commonly filled with a combination propylene glycol, glycerin, and drugs such as nicotine or tetrahydrocannabinol as a liquid solution.
The European Centre for Disease Prevention and Control (ECDC) is an agency of the European Union (EU) whose mission is to strengthen Europe's defences against infectious diseases. It covers a wide spectrum of activities, such as: surveillance, epidemic intelligence, response, scientific advice, microbiology, preparedness, public health training, international relations, health communication, and the scientific journal Eurosurveillance. The centre was established in 2004 and is headquartered in Solna, Sweden.
Respiratory tract infections (RTIs) are infectious diseases involving the respiratory tract. An infection of this type usually is further classified as an upper respiratory tract infection or a lower respiratory tract infection. Lower respiratory infections, such as pneumonia, tend to be far more severe than upper respiratory infections, such as the common cold.
Chest is a peer-reviewed medical journal covering chest diseases and related issues, including pulmonology, cardiology, thoracic surgery, transplantation, breathing, airway diseases, and emergency medicine. The journal was established in 1935. It is the official journal of the American College of Chest Physicians which publishes the journal. The editor-in-chief is Peter Mazzone.
Nature Medicine is a monthly peer-reviewed medical journal published by Nature Portfolio covering all aspects of medicine. It was established in 1995. The journal seeks to publish research papers that "demonstrate novel insight into disease processes, with direct evidence of the physiological relevance of the results". As with other Nature journals, there is no external editorial board, with editorial decisions being made by an in-house team, although peer review by external expert referees forms a part of the review process. The editor-in-chief is João Monteiro.
Respiratory Medicine is a monthly peer-reviewed medical journal published by Elsevier covering research in pulmonology.According to the Journal Citation Reports, Respiratory Medicine has a 2020 impact factor of 3.415.
Expert Opinion on Pharmacotherapy is a peer-reviewed medical journal publishing review articles and original papers on new pharmacotherapies. It is published by Informa and the editor-in-chief is Dimitri P. Mikhailidis.
The American Journal of Respiratory and Critical Care Medicine is a biweekly peer-reviewed medical journal published by the American Thoracic Society. It covers the pathophysiology and treatment of diseases that affect the respiratory system, as well as topics of fundamental importance to the practice of pulmonary, critical care, and sleep medicine. It was established in March 1917 as the American Review of Tuberculosis. Since then there have been several title changes. In 1953 a subtitle was added, "A Journal of Pulmonary Diseases." In 1955 the title became the American Review of Tuberculosis and Pulmonary Diseases, and in 1959 the American Review of Respiratory Diseases. The journal obtained its current title in 1994.
The American Journal of Respiratory Cell and Molecular Biology is a monthly peer-reviewed medical journal and an official publication of the American Thoracic Society. It covers research on the structure and function of the respiratory system under physiologic and pathophysiologic conditions. It was established in July 1989. The founding editors-in-chief were Jerome S. Brody, Robert M. Senior, and Mary C. Williams. John A. Mcdonald served as editor from 1993 to 1998. Kenneth B. Adler served as editor from 2009 to 2016. Paul Schumacker assumed the editorship on October 1, 2016.
The Annals of the American Thoracic Society is an official medical journal of the American Thoracic Society (ATS). It publishes original clinical and epidemiological research in the fields of pulmonology, critical care medicine, and sleep medicine. Known colloquially as the "White Journal", the Annals of the American Thoracic Society is one of four journals published by the American Thoracic Society, along with the American Journal of Respiratory and Critical Care Medicine, American Journal of Respiratory Cell and Molecular Biology, and ATS Scholar.
Thorax is a monthly peer-reviewed medical journal specialising in both clinical and experimental research articles on respiratory medicine as well as paediatrics, immunology, pharmacology, pathology, and surgery. It was established in 1946 and is published by the BMJ Group on behalf of the British Thoracic Society. The journal is available online by subscription and archived editions of the journal are available free of charge after 1 year. The editors-in-chief are
The European Respiratory Society, or ERS, is a non-profit organization with offices in Lausanne, Brussels and Sheffield. It was founded in 1990 in the field of respiratory medicine. The organization was formed with the merger of the Societas Europaea Physiologiae Clinicae Respoiratoriae and the European Society of Pneumology. The organization's membership is made up of medical professionals and scientists working in the area of respiratory medicine.
Respiratory Research is an open access peer-reviewed medical journal published by BioMed Central. It covers all aspects of respiratory disease, including clinical and basic research. The journal publishes research articles, commentaries, letters to the editor, and reviews.
Respirology is a peer-reviewed medical journal published by Wiley on behalf of the Asian Pacific Society of Respirology. The word respirology is derived from the Latin root respirare, "to breathe" and the Greek root logos, "knowledge". The journal covers clinical respiratory biology and disease, including epidemiology, intensive and critical care medicine, pathology, physiology, thoracic surgery, and general medicine, as it relates to respiratory biology and disease.
Allison Joan McGeer is a Canadian infectious disease specialist in the Sinai Health System, and a professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. She also appointed at the Dalla Lana School of Public Health and a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute, and is a partner of the National Collaborating Centre for Infectious Diseases. McGeer has led investigations into the severe acute respiratory syndrome outbreak in Toronto and worked alongside Donald Low. During the COVID-19 pandemic, McGeer has studied how SARS-CoV-2 survives in the air and has served on several provincial committees advising aspects of the Government of Ontario's pandemic response.
